We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Multinational Study of Acinetobacter Bloodstream Infection: Clinical Outcomes and Global Epidemiology-PITT Protocol

This study is currently recruiting participants.
Verified June 2017 by Yohei Doi, University of Pittsburgh
Sponsor:
ClinicalTrials.gov Identifier:
NCT00524290
First Posted: September 3, 2007
Last Update Posted: June 9, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Information provided by (Responsible Party):
Yohei Doi, University of Pittsburgh
August 31, 2007
September 3, 2007
June 9, 2017
April 2009
December 2025   (Final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT00524290 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Multinational Study of Acinetobacter Bloodstream Infection: Clinical Outcomes and Global Epidemiology-PITT Protocol
Multinational Study of Acinetobacter Bloodstream Infection: Clinical Outcomes and Global Epidemiology-PITT Protocol
The objectives of this multinational study are to assess the clinical outcomes of patients with Acinetobacter bloodstream infection and to further assess the predictors of mortality in this patient population. We also aim to characterize the molecular epidemiology of this remarkable organism in an attempt to further understand its transmission dynamics on a global level and to determine whether increased pathogenicity is geographically dependent.
Medical records will be reviewed and information collected to assess the clinical outcomes of patients with Acinetobacter bloodstream infection and to further assess the predictors of mortality in this patient population.
Observational
Observational Model: Cohort
Time Perspective: Retrospective
Not Provided
Not Provided
Probability Sample
acinetobacter infections
Acinetobacter Infections
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
100
December 2025
December 2025   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Patients with Acinetobacter infections

Exclusion Criteria:

  • Those that do not meet entry criteria
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact: David Paterson, MD 412-648-6553 david.antibiotics@gmail.com
Contact: Diana Lynn Pakstis, RN, BSN 412-648-6553 pakstisdl@dom.pitt.edu
United States
 
 
NCT00524290
PRO07080043
Yes
Not Provided
Not Provided
Yohei Doi, University of Pittsburgh
University of Pittsburgh
Not Provided
Principal Investigator: David Paterson, MD University of Pittsburgh
University of Pittsburgh
June 2017